Literature DB >> 30737174

Discovery and Characterization of Cas9 Inhibitors Disseminated across Seven Bacterial Phyla.

Ruben V Uribe1, Eric van der Helm1, Maria-Anna Misiakou1, Sang-Woo Lee1, Stefan Kol1, Morten O A Sommer2.   

Abstract

CRISPR-Cas systems in bacteria and archaea provide immunity against bacteriophages and plasmids. To overcome CRISPR immunity, phages have acquired anti-CRISPR genes that reduce CRISPR-Cas activity. Using a synthetic genetic circuit, we developed a high-throughput approach to discover anti-CRISPR genes from metagenomic libraries based on their functional activity rather than sequence homology or genetic context. We identified 11 DNA fragments from soil, animal, and human metagenomes that circumvent Streptococcus pyogenes Cas9 activity in our selection strain. Further in vivo and in vitro characterization of a subset of these hits validated the activity of four anti-CRISPRs. Notably, homologs of some of these anti-CRISPRs were detected in seven different phyla, namely Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, Cyanobacteria, Spirochaetes, and Balneolaeota, and have high sequence identity suggesting recent horizontal gene transfer. Thus, anti-CRISPRs against type II-A CRISPR-Cas systems are widely distributed across bacterial phyla, suggesting a more complex ecological role than previously appreciated.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas9 inhibitor; anti-CRISPR; functional metagenomics; genetic circuit

Mesh:

Substances:

Year:  2019        PMID: 30737174     DOI: 10.1016/j.chom.2019.01.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  21 in total

1.  Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.

Authors:  Max J Gramelspacher; Zhonggang Hou; Yan Zhang
Journal:  Methods       Date:  2019-06-20       Impact factor: 3.608

2.  Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4.

Authors:  Ruchao Peng; Zhiteng Li; Ying Xu; Shaoshuai He; Qi Peng; Lian-Ao Wu; Ying Wu; Jianxun Qi; Peiyi Wang; Yi Shi; George F Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-29       Impact factor: 11.205

Review 3.  Three New Cs for CRISPR: Collateral, Communicate, Cooperate.

Authors:  Andrew Varble; Luciano A Marraffini
Journal:  Trends Genet       Date:  2019-04-27       Impact factor: 11.639

4.  PaCRISPR: a server for predicting and visualizing anti-CRISPR proteins.

Authors:  Jiawei Wang; Wei Dai; Jiahui Li; Ruopeng Xie; Rhys A Dunstan; Christopher Stubenrauch; Yanju Zhang; Trevor Lithgow
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

5.  Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.

Authors:  Guoxu Song; Fei Zhang; Chunhong Tian; Xing Gao; Xiaoxiao Zhu; Dongdong Fan; Yong Tian
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

6.  Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes.

Authors:  Andrew Varble; Edmondo Campisi; Chad W Euler; Pascal Maguin; Albina Kozlova; Jessica Fyodorova; Jakob T Rostøl; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Microbiol       Date:  2021-11-24       Impact factor: 17.745

7.  Machine learning predicts new anti-CRISPR proteins.

Authors:  Simon Eitzinger; Amina Asif; Kyle E Watters; Anthony T Iavarone; Gavin J Knott; Jennifer A Doudna; Fayyaz Ul Amir Afsar Minhas
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

Review 8.  The arms race between bacteria and their phage foes.

Authors:  Hannah G Hampton; Bridget N J Watson; Peter C Fineran
Journal:  Nature       Date:  2020-01-15       Impact factor: 49.962

Review 9.  Type II anti-CRISPR proteins as a new tool for synthetic biology.

Authors:  Yadan Zhang; Mario Andrea Marchisio
Journal:  RNA Biol       Date:  2020-10-13       Impact factor: 4.652

Review 10.  Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies.

Authors:  Rafael Pinilla-Redondo; Bálint Csörgő; Nicole D Marino; Joseph Bondy-Denomy
Journal:  Nat Methods       Date:  2020-03-16       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.